Your Epilepsy Toolkit

For more than 20 years, UCB has been dedicated to creating effective epilepsy treatments to help improve the lives of people living with epilepsy and their loved ones.

The following resources are provided by UCB to help in your search for information about epilepsy, seizures, and the treatment that you deserve.

Neurologist Discussion Guide

When you visit your neurologist, you probably talk about your seizures, side effects, and treatment. That’s important. But have you ever sat down and discussed what you really want from treatment? And what your life might be like if you could achieve your treatment goals? You and your neurologist need to discuss this, too. Download the Neurologist Discussion Guide now to get started.

Epilepsy Advocate is a community of people and their families living with all types of epilepsy. Visit EpilepsyAdvocate.com for:

Inspiring stories and videos
Practical advice about epilepsy
Ways to connect with other people with epilepsy

Sign up to get inspiring monthly e-mails and our magazine EpilepsyAdvocate^™—full of information that people living with epilepsy and their caregivers can use every day. You can also learn more about our educational events in your local area. Get the details about a meeting near you and a chance to connect with members of the epilepsy community.http://www.epilepsyadvocate.com

Patient Assistance Program

UCB, the Epilepsy Company, is here to help if your insurance company won’t cover the cost of your epilepsy medication. To find out whether you qualify for the UCB Patient Assistance Program, please call customer service at 866-395-8366. These two downloads will help you get started:

EpilepsyClassroom.com offers tools and resources that help bring epilepsy into the classroom—so administrators, teachers, parents, and students can help teach other people in their schools about epilepsy.http://www.epilepsyclassroom.com

The UCB Family Epilepsy Scholarship Program^™ provides financial support to encourage academic and personal achievement not just to people with epilepsy but also to the family members and caregivers who contribute to their successes. UCB, Inc. awards thirty $5,000 scholarships a year and since 2005 has awarded over a half million dollars in scholarships.http://epilepsyadvocate.com/resources/scholarship.aspx

"The UCB Family Epilepsy Scholarship Program" and "The Epilepsy Advocate" are trademarks of the UCB Group of Companies.

Next: Epilepsy Resources

Save Now on VIMPAT

Get 14 days for free and
save up to $30 on each of
your next 12 prescriptions.

Enroll Today

Epilepsy Independence Can Be Possible

Vimpat Advantage will help
you get there.

Enroll Today

Over 800,000 people taking epilepsy medicine are still having seizures. Now there's hope for seizure control. Now there's Vimpat.

Indication

Vimpat^® (lacosamide) is a prescription medicine that is used with other medicines to treat partial-onset seizures in people 17 years of age and older with epilepsy.

Important Safety Information

Vimpat is generally well-tolerated, but may not be for everyone. Ask your healthcare provider if Vimpat is right for you.

Warnings and Precautions

Antiepileptic drugs, including Vimpat, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that you have never had before or may be worse than before. Do not stop taking Vimpat without first talking to your healthcare provider. Stopping Vimpat suddenly can cause serious problems.

Vimpat may also cause you to feel dizzy, have double vision, feel sleepy, or have problems with coordination and walking. You should not drive, operate machinery or do other dangerous activities until you know how Vimpat affects you.

Vimpat may cause you to have an irregular heartbeat or may cause you to feel faint. Call your healthcare provider if you have a fast, slow, or pounding heartbeat, shortness of breath, feel lightheaded, or if you fainted or feel like you are going to faint.

Vimpat is classified as a federally controlled substance (C-V) due to a low potential for abuse. Keep your Vimpat in a safe place and do not give it to anyone else.

In rare cases, Vimpat may cause a serious allergic reaction that may affect your skin or other parts of your body such as your liver or blood cells. Call your healthcare provider right away if you have a skin rash or hives, fever or swollen glands that do not go away, shortness of breath, swelling of the legs, yellowing of the skin or whites of the eyes, or dark urine.

Vimpat oral solution contains aspartame, a source of phenylalanine.

Common Adverse Reactions

The most common side effects with Vimpat are dizziness, headache, nausea, and double vision. To report Suspected Adverse Reactions, contact UCB, Inc. at 866-822-0068 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please see additional patient information in the Patient Medication Guide. This information does not take the place of talking with your healthcare provider about your condition or your treatment.

VIMPAT (lacosamide) tablets injection

Print
E-mail

*Indicates a required field

Recipient's Name*

Recipient's E-mail Address*